AnalystBook Research · Company Intelligence

Apollo Commercial Real Estate Finance, Inc.

ARINYSE

Built from Apollo Commercial Real Estate Finance, Inc.'s own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

Apollo Commercial Real Estate Finance revenue fell 10.6% to $271.6M, while net income rebounded to $126.7M.

The read at a glance✓ Audited against SEC data
  • Business mixCommercial real-estate finance REITNote
  • RevenueRevenue fell 10.6% to $271.6MWatch
  • ProfitabilityNet income rebounded to $126.7MOK
  • CashCash from ops fell 28.8%Watch
  • Balance sheetEquity was $1.86BNote
  • Insiders0 buys / 2 sellsWatch
  • AccountingForensic screen unavailableNote

Business

Apollo Commercial Real Estate Finance is a REIT externally managed by an Apollo affiliate and focused on commercial real-estate debt investments.

Leadership changes

From Apollo Commercial Real Estate Finance, Inc.'s own filings, the day they're filed.

  • Apollo Commercial Real Estate · director · departureeff. 2026-05-14
  • Apollo Commercial Real Estate · director · departureeff. 2024-01-31

Latest filings

  • 8-K · Company announcement2026-08-11
  • 10-Q · Quarterly report2026-08-10
  • 8-K · Company announcement2026-07-13
  • 8-K · Company announcement2026-06-16
  • DEF 14A · Annual proxy (pay & governance)2026-05-29
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • Main tension🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about Apollo Commercial Real Estate Finance, Inc., every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.